---
title: "12 Health Care Stocks Moving In Monday's After-Market Session"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295454408.md"
description: "Healthcare stocks showed mixed performance in Monday's after-market session, largely driven by Q2 earnings reports. P3 Health Partners surged 24.1% to $15.92, while Definitive Healthcare rose 10.23%. Conversely, Tactile Systems Tech dropped 17.8% to $23.95, and RenovoRx fell 9.49%. Other notable movers included Iridex, Evolent Health, Alcon, Olema Pharmaceuticals, and Sana Biotechnology."
datetime: "2026-08-10T21:06:23.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295454408.md)
  - [en](https://longbridge.com/en/news/295454408.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295454408.md)
---

# 12 Health Care Stocks Moving In Monday's After-Market Session

### Gainers

-   **P3 Health Partners** (NASDAQ:PIII) shares increased by 24.1% to $15.92 during Monday's after-market session. The market value of their outstanding shares is at $38.5 million. As per the press release, Q2 earnings came out today.
-   **Definitive Healthcare** (NASDAQ:DH) shares increased by 10.23% to $0.77. The market value of their outstanding shares is at $75.2 million. As per the press release, Q2 earnings came out today.
-   **Iridex** (NASDAQ:IRIX) stock rose 7.47% to $0.9. The company's market cap stands at $14.4 million.
-   **Werewolf Therapeutics** (NASDAQ:HOWL) stock rose 6.72% to $0.41. The company's market cap stands at $19.2 million.
-   **Evolent Health** (NYSE:EVH) stock rose 6.1% to $4.17. The company's market cap stands at $446.5 million. As per the news, the Q2 earnings report came out 2 days ago.
-   **Alcon** (NYSE:ALC) shares increased by 4.98% to $77.3. The company's market cap stands at $35.5 billion. As per the press release, Q2 earnings came out today.

### Losers

-   **Tactile Systems Tech** (NASDAQ:TCMD) shares decreased by 17.8% to $23.95 during Monday's after-market session. The market value of their outstanding shares is at $665.4 million. As per the news, the Q2 earnings report came out today.
-   **RenovoRx** (NASDAQ:RNXT) stock decreased by 9.49% to $1.05. The market value of their outstanding shares is at $50.5 million.
-   **Pomdoctor** (NASDAQ:POM) stock decreased by 8.26% to $1.0. The market value of their outstanding shares is at $103.1 million.
-   **Olema Pharmaceuticals** (NASDAQ:OLMA) shares fell 7.29% to $11.08. The market value of their outstanding shares is at $1.0 billion. As per the news, the Q2 earnings report came out today.
-   **Sana Biotechnology** (NASDAQ:SANA) stock decreased by 6.65% to $3.37. The market value of their outstanding shares is at $979.5 million. The company's, Q2 earnings came out today.
-   **Purple Biotech** (NASDAQ:PPBT) stock decreased by 6.65% to $1.4. The market value of their outstanding shares is at $1.3 million. As per the news, the Q2 earnings report came out yesterday. **See Also:** www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

### Related Stocks

- [SANA.US](https://longbridge.com/en/quote/SANA.US.md)
- [ALC.US](https://longbridge.com/en/quote/ALC.US.md)
- [PIII.US](https://longbridge.com/en/quote/PIII.US.md)
- [OLMA.US](https://longbridge.com/en/quote/OLMA.US.md)
- [TCMD.US](https://longbridge.com/en/quote/TCMD.US.md)
- [DH.US](https://longbridge.com/en/quote/DH.US.md)
- [IRIX.US](https://longbridge.com/en/quote/IRIX.US.md)
- [RNXT.US](https://longbridge.com/en/quote/RNXT.US.md)
- [EVH.US](https://longbridge.com/en/quote/EVH.US.md)
- [HOWL.US](https://longbridge.com/en/quote/HOWL.US.md)
- [POM.US](https://longbridge.com/en/quote/POM.US.md)
- [PPBT.US](https://longbridge.com/en/quote/PPBT.US.md)
- [PIIIW.US](https://longbridge.com/en/quote/PIIIW.US.md)

## Related News & Research

- [ALC: Strong sales growth offset by a major impairment charge led to sharply lower earnings](https://longbridge.com/en/news/295486138.md)
- [Eye care company Alcon raises margin outlook, shares jump](https://longbridge.com/en/news/295501993.md)
- [Definitive Healthcare Q2 revenue slightly misses estimates despite customer gains](https://longbridge.com/en/news/295445972.md)
- [EXCLUSIVE: Renovorx Advances Its Targeted Pancreatic Cancer Therapy, Pivotal Data Expected in 2027](https://longbridge.com/en/news/295533800.md)
- [SANA: Advancing hypoimmune cell therapies for T1D and in vivo CAR T cells, with key trials in 2026](https://longbridge.com/en/news/295462698.md)